Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › SC › Beaufort › NPI 1508518069
Physician

Southern Coast Spine and Pain Specialists LLC

Southern Coast Spine and Pain Specialists LLC was paid $618K by Medicaid between Jul 2022 and Nov 2024, across 30 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 42% of everything it billed.

33Billing provider infoSOUTHERN COAST SPINE AND PAIN SPECIALISTS LLC
BEAUFORT, SC 29902
33aNPI1508518069assigned 01/25/2022
28Total paid$618K
24GClaims20,995
24DCodes billed30
24AFirst – last monthJul 2022 – Nov 2024
Compared with peers

Next to other Pain Medicine (Anesthesiology) Physician providers in South Carolina

Rank by total paid#4 of 25
Median peer was paid$41K
This provider vs. median15×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20221,801$79K
20239,764$287K
2024incomplete9,430$252K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 42% 7,658 6,968 $260K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 20% 3,423 3,243 $121K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 15% 2,211 2,077 $90K
62323 5.3% 435 407 $33K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 3.7% 355 350 $23K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3.4% 494 457 $21K
99152 2.7% 1,064 953 $17K
64483 1.7% 147 135 $11K
62321 1.4% 92 86 $8K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 788 733 $6K
77002 <1% 156 148 $4K
64493 <1% 84 77 $4K
18 more codes
64635 <1% 29 $4K
20610 <1% 122 $3K
99203 Doctor's office visit, new patient (routine) <1% 46 $3K
72110 <1% 90 $2K
64636 <1% 28 $1K
72190 <1% 85 $1K
64494 <1% 51 $1K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 225 $898.87
72050 <1% 31 $621.46
J1010 Injection, methylprednisolone acetate, 1 mg <1% 507 $527.15
64484 <1% 17 $466.30
73564 <1% 31 $351.20
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 1,173 $198.26
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,285 $173.04
80305 <1% 13 $154.57
J3490 Unclassified drugs <1% 153 $27.18
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 0% 190 $0.00
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHUYLER, WALTER (OWNER)
Same official

Other billing entities under SCHUYLER, WALTER

Full network →
ProviderLocationPaid
Southern Coast Pain SpecialistsBeaufort, SC$473K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.